- Home
- CDXS vs CMPS Comparison
CDXS vs CMPS Comparison
Compare CDXS & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- CMPS
- Stock Information
- Founded
- CDXS 2002
- CMPS 2020
- Country
- CDXS United States
- CMPS United Kingdom
- Employees
- CDXS N/A
- CMPS N/A
- Industry
- CDXS Major Chemicals
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- CDXS Industrials
- CMPS Health Care
- Exchange
- CDXS Nasdaq
- CMPS Nasdaq
- Market Cap
- CDXS 332.0M
- CMPS 280.2M
- IPO Year
- CDXS 2010
- CMPS 2020
- Fundamental
- Price
- CDXS $5.28
- CMPS $4.00
- Analyst Decision
- CDXS Buy
- CMPS Strong Buy
- Analyst Count
- CDXS 2
- CMPS 6
- Target Price
- CDXS $11.00
- CMPS $33.60
- AVG Volume (30 Days)
- CDXS 875.4K
- CMPS 705.9K
- Earning Date
- CDXS 10-31-2024
- CMPS 10-31-2024
- Dividend Yield
- CDXS N/A
- CMPS N/A
- EPS Growth
- CDXS N/A
- CMPS N/A
- EPS
- CDXS N/A
- CMPS N/A
- Revenue
- CDXS $64,446,000.00
- CMPS N/A
- Revenue This Year
- CDXS N/A
- CMPS N/A
- Revenue Next Year
- CDXS $2.02
- CMPS N/A
- P/E Ratio
- CDXS N/A
- CMPS N/A
- Revenue Growth
- CDXS N/A
- CMPS N/A
- 52 Week Low
- CDXS $2.53
- CMPS $3.86
- 52 Week High
- CDXS $6.08
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- CDXS 59.97
- CMPS 37.40
- Support Level
- CDXS $5.42
- CMPS $3.86
- Resistance Level
- CDXS $6.01
- CMPS $4.91
- Average True Range (ATR)
- CDXS 0.39
- CMPS 0.28
- MACD
- CDXS -0.05
- CMPS -0.01
- Stochastic Oscillator
- CDXS 46.67
- CMPS 16.59
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.